Jean‐Philippe Ryckelynck

Once-Monthly Subcutaneous C.E.R.A. Maintains Stable Hemoglobin Control in Patients with Chronic Kidney Disease on Dialysis and Converted Directly from Epoetin One to Three Times Weekly

Francesco Locatelli, Jean‐Philippe Ryckelynck, József Balla et al. · Clinical Journal of the American Society of Nephrology · 2007 · 137 citations

Is Assisted Peritoneal Dialysis Associated with Technique Survival When Competing Events Are Considered?

Thierry Lobbedez, Christian Verger, Jean‐Philippe Ryckelynck et al. · Clinical Journal of the American Society of Nephrology · 2012 · 114 citations

Assisted Peritoneal Dialysis. Experience in a French Renal Department

Thierry Lobbedez, Raluca Moldovan, Marie Lecame et al. · Peritoneal Dialysis International · 2006 · 112 citations

The Referral Pattern of Patients with Esrd is a Determinant in the Choice of Dialysis Modality

Norbert Lameire, Wim Van Biesen, Nicholas Dombros et al. · Peritoneal Dialysis International · 1997 · 80 citations

Hemodialysis, Urology, Renal Disease +10

Clinical Pharmacokinetics of Ketoprofen After Single Intravenous Administration as a Bolus or Infusion

Danièle Debruyne, Bruno Hurault de Ligny, Jean‐Philippe Ryckelynck et al. · Clinical Pharmacokinetics · 1987 · 51 citations

Single Intravenous Administration, Local Pharmacology, Pharmacology +4